- Home
- EWTX vs AHCO Comparison
EWTX vs AHCO Comparison
Compare EWTX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- AHCO
- Stock Information
- Founded
- EWTX 2017
- AHCO 2012
- Country
- EWTX United States
- AHCO United States
- Employees
- EWTX N/A
- AHCO N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- AHCO Medical/Nursing Services
- Sector
- EWTX Health Care
- AHCO Health Care
- Exchange
- EWTX Nasdaq
- AHCO Nasdaq
- Market Cap
- EWTX 1.2B
- AHCO 1.2B
- IPO Year
- EWTX 2021
- AHCO N/A
- Fundamental
- Price
- EWTX $14.30
- AHCO $8.39
- Analyst Decision
- EWTX Buy
- AHCO Strong Buy
- Analyst Count
- EWTX 8
- AHCO 5
- Target Price
- EWTX $39.63
- AHCO $13.40
- AVG Volume (30 Days)
- EWTX 932.9K
- AHCO 950.2K
- Earning Date
- EWTX 08-07-2025
- AHCO 08-05-2025
- Dividend Yield
- EWTX N/A
- AHCO N/A
- EPS Growth
- EWTX N/A
- AHCO N/A
- EPS
- EWTX N/A
- AHCO 0.58
- Revenue
- EWTX N/A
- AHCO $3,246,360,000.00
- Revenue This Year
- EWTX N/A
- AHCO $1.72
- Revenue Next Year
- EWTX N/A
- AHCO $4.52
- P/E Ratio
- EWTX N/A
- AHCO $14.64
- Revenue Growth
- EWTX N/A
- AHCO N/A
- 52 Week Low
- EWTX $10.60
- AHCO $7.11
- 52 Week High
- EWTX $38.12
- AHCO $11.90
- Technical
- Relative Strength Index (RSI)
- EWTX 41.90
- AHCO 38.59
- Support Level
- EWTX $14.87
- AHCO $8.33
- Resistance Level
- EWTX $15.68
- AHCO $9.18
- Average True Range (ATR)
- EWTX 0.67
- AHCO 0.31
- MACD
- EWTX -0.02
- AHCO -0.06
- Stochastic Oscillator
- EWTX 15.25
- AHCO 7.06
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.